Yunjo Soh , Visiting researcher
1) Elucidation of the signal transduction pathways involved in bone remodeling.
2) Discovery of biomodulators for Bone formation and Chondrogenic differentiation.
3) Elucidation of the signal transduction pathways involved in tissue damage caused by hypoxic stress/reactive oxygen species.
1979, 3 - 1984, 2 Seoul National University, B.S. in Pharmacy, Seoul, Korea
1984, 3 - 1986, 2 Seoul National University M.S. in Pharmacy, Seoul Korea
1988, 1 - 1993, 3 Auburn University, Ph.D. AL. USA
Choi HJ, Nepal M, Park YR, Lee HK, Oh SR, Soh Y. Stimulation of chondrogenesis in ATDC5
chondroprogenitor cells and hypertrophy in mouse by Genkwadaphnin. Eur J Pharmacol., 2011 Mar 25;655 (1-3):9-15.
Nepal M, Gong YD, Park YR, Soh Y. An activator of PHD2, KRH102140, decreases
angiogenesis via inhibition of HIF-1α. Cell Biochemistry & Function, 2011 Mar;29(2):126-34.
Choi B-Y, Eun JS, Nepal M, Soh Y. Ethyl Docosahexaenoate and its acidic form increase bone
formation by induction of osteoblast differentiation and inhibition of osteoclastogenesis. Biomolecules & Therapeutics, 2011 (19)1: 70-76.
Choi HJ, Park YR, Nepal M, Choi BY, Cho NP, Choi SH, Heo SR, Kim HS, Yang MS, Soh Y.
Inhibition of osteoclastogenic differentiation by Ikarisoside A in RAW 264.7 cells via JNK and NF-kappaB signaling pathways. Eur J Pharmacol. 2010 June 25; 636(1-3):28-35.
Discovery of biomodulators for Bone formation from marine resources.